title: Expression of beta 1- and beta 2-receptor genes and correlation to lipolysis in human adipose tissue during childhood.
abstract: beta 1- and beta 2-adrenoceptor (bar1 and bar2) mRNA levels were measured in adipose tissue obtained from children (between 1 month and 10 yr of age) and adults during inguinal hernia operations. Bar1 mRNA levels were constant in all age groups studied. In infants and children less than 7 yr old, bar2 levels were twice as high (P < 0.01) as those in adults, and in infants 1-4 months old, bar2 mRNA levels were higher than bar1 levels (P < 0.01). The bar2/bar1 ratio gradually decreased, and in adults, there was 2.3-fold higher bar1 mRNA expression (P < 0.01). In infants 1-5 months old, the lipolytic sensitivity to noradrenaline was 5 times lower (P < 0.05) than that in adults, whereas the sensitivity to adrenaline and isoprenaline was unchanged. The maximal lipolytic response to adrenaline was higher than that to noradrenaline in infants (P < 0.01), whereas the opposite was found in adults (P < 0.01). The lipolytic sensitivity to the bar1-selective agonist dobutamine was not influenced by age, whereas the sensitivity to the bar2-selective agonist terbutaline was 10,000 times higher in infants than in adults. In conclusion, these data indicate subtype-specific developmental changes in bar expression, with higher bar2 mRNA levels accompanied by increased bar2-induced lipolysis during infancy.
authors.affiliation: Department of Pediatrics, Huddinge University Hospital, Sweden.
authors.forename: C
authors.initials: C
authors.lastname: Marcus
authors.forename: P
authors.initials: P
authors.lastname: Bolme
authors.forename: B
authors.initials: B
authors.lastname: Karpe
authors.forename: M
authors.initials: M
authors.lastname: Brönnegård
authors.forename: H
authors.initials: H
authors.lastname: Selldén
authors.forename: P
authors.initials: P
authors.lastname: Arner
mesh_terms: D000273:Adipose Tissue / Q000378:metabolism*; D000318:Adrenergic beta-Agonists / Q000494:pharmacology; D000328:Adult; D002395:Catecholamines / Q000494:pharmacology; D002648:Child; D002657:Child Development; D002675:Child, Preschool; D005260:Female; D015870:Gene Expression; D006801:Humans; D007223:Infant; D007231:Infant, Newborn; D008066:Lipolysis; D008297:Male; D008875:Middle Aged; D012333:RNA, Messenger / Q000378:metabolism; D011943:Receptors, Adrenergic, beta / Q000235:genetics*
chemical_list: D000318:Adrenergic beta-Agonists; D002395:Catecholamines; D012333:RNA, Messenger; D011943:Receptors, Adrenergic, beta